Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jennifer Legardy-Williams"'
Autor:
Rosalind J Carter, Olamide D Jarrett, Elena Szefer, Barbara E. Mahon, Mohamed Samai, Susan T. Goldstein, Sarah C. Tinker, Jennifer Legardy-Williams, Augustin E Fombah
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 541-548 (2020)
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 541-548 (2020)
Little information exists regarding Ebola vaccine rVSVΔGZEBOV-GP and pregnancy. The Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE) randomized participants without blinding to immediate or deferred (18-24 weeks postenrollment) vacci
Autor:
Marc E Fischer, Wendi McDonald, Stephanie J. Schrag, Foday Sahr, Laura Gibson, Concepcion F. Estivariz, Anne Schuchat, Sara Hersey, Roselyn M’baindu Momoh, Joseph S. Bresee, Wendy Carr, Dayo Spencer-Walters, Stacie M. Greby, Jennifer Legardy-Williams, Ahamed Flagbata Kallon, Amanda C. Cohn, Jane F. Seward, Ayesha Idriss, Rosalind J Carter, Winston Webber, Joseph Edem-Hotah, Melvina Thompson, Mohamed Samai, Marc-Alain Widdowson, Julianne Gee, Stephen C. Hadler, Amy Callis
Publikováno v:
The Journal of Infectious Diseases. 217:S16-S23
The Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE), a phase 2/3 trial of investigational rVSV∆G-ZEBOV-GP vaccine, was conducted during an unprecedented Ebola epidemic. More than 8600 eligible healthcare and frontline response work
Autor:
S A S Kargbo, Wendy Carr, Olamide D Jarrett, Mohamed I Jalloh, Mohamed Samai, Augustin E Fombah, Wendi McDonald, Anne Schuchat, Marc-Alain Widdowson, Robert E Walker, Paul Gargiullo, James B.W. Russell, Brima Kargbo, Robert Lindblad, Rosalind J Carter, Jane F. Seward, Donald Bash-Taqi, Stephanie J. Schrag, Bailah Leigh, Gibrilla F. Deen, Amy Callis, Durodami Radcliffe Lisk, Strive Study Team, Barbara E. Mahon, Carey R. Petrie, Susan T. Goldstein, Laura Gibson, Abu Bakarr Fofanah, Jennifer Legardy-Williams, Ayesha Idriss, Peter Dawson, Mohamed Bawoh
Publikováno v:
The Journal of Infectious Diseases. 217:S6-S15
The West Africa Ebola epidemic stimulated rapid implementation of Ebola vaccine trials in the 3 highly affected countries. In Sierra Leone, we studied the recombinant vesicular stomatitis virus Ebola vaccine (rVSV∆G-ZEBOV-GP) safety and efficacy. T
Autor:
Augustin E Fombah, Gibrilla F. Deen, Muhammad-Abbas Conteh, Mohamed M Bah, Jennifer Legardy-Williams, Faustine James, Mohamed I Jalloh, Patrick E Turay, Jibao D Sandy, Barbara E. Mahon, Mohamed Samai, Laurence Slutsker, Dudley A Pratt, Durodami Radcliffe Lisk, Olamide D Jarrett, John F Yillia, Jane F. Seward, James B.W. Russell, Susan T. Goldstein, Stephanie J. Schrag, Peter Dawson, Robert Lindblad, Jill El-Khorazaty, Wendy Carr, Peter Matthew George
Publikováno v:
The Journal of Infectious Diseases. 217:S75-S80
The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE), a clinical trial of the investigational recombinant vesicular stomatitis virus–based Ebola virus vaccine (rVSV∆ZEBOV-GP; Merck), provided an opportunity to assess health condit
Autor:
Willietta Vincent, Mohamed Samai, Mahnaz Motevalli, Barbara E. Mahon, Jennifer Legardy-Williams, Abdul Karim Kabineh, Wendy Carr
Publikováno v:
The Journal of Infectious Diseases. 217:S56-S59
International regulatory standards ensure human subjects protection, data quality, and scientific integrity of clinical trials. Operationalizing regulatory standards during a large vaccine clinical trial—the Sierra Leone Trial to Introduce a Vaccin
Autor:
Tina Hylton-Kong, Christi Phillips, Jennifer Legardy-Williams, Sinmisola Ewumi, Elizabeth Costenbader, Lee Warner, Lisa Flowers, Athena P. Kourtis, Jeffrey Wiener, John R. Papp, Carolyn M. Black, Margaret C. Snead, Natalie Medley-Singh
Publikováno v:
Sexually Transmitted Infections. 93:503-507
Background There is limited information on rates of STIs in Jamaica due to syndromic management and limited aetiological surveillance. We examined the prevalence of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV)
Autor:
Maria F. Gallo, Natalie Medley-Singh, Jennifer Legardy-Williams, Margaret C. Snead, Denise J. Jamieson, Jeffrey Wiener, Carole Rattray, Lee Warner, Markus J. Steiner, Tina Hylton-Kong, Karen Pazol, Athena P. Kourtis, Elizabeth Costenbader
Publikováno v:
Contraception. 92:560-566
Objective To evaluate whether initiation of a contraceptive implant, a method of long-acting reversible contraception, reduces condom use, as measured by a biomarker of recent semen exposure [prostate-specific antigen (PSA)]. Study design We conducte
Autor:
Maria F. Gallo, Tina Hylton-Kong, Denise J. Jamieson, Jeffrey Wiener, Markus J. Steiner, Jennifer Legardy-Williams, Maurizio Macaluso, Marcia M. Hobbs, J P Figueroa, Clive Anderson, Lee Warner
Publikováno v:
Sexually Transmitted Diseases. 40:105-110
The World Health Organization estimates 340 million new cases of sexually transmitted infections (STIs) occur annually worldwide, with the rate of new infections in Latin America and the Caribbean second only to that of sub-Saharan Africa.1 Because S
Autor:
Michelle Basket, Wendi McDonald, Kelli R Clifton Ogunsanya, Barbara E. Mahon, Marc-Alain Widdowson, Victoria M Carter, Gibrilla F. Deen, Laura Gibson, Robert W. Pinner, Wendy Carr, Mohamed Samai, Stephanie J. Schrag, Jane F. Seward, Mohamed I Jalloh, Amy Callis, James B.W. Russell, Jennifer Legardy-Williams, Susan T. Goldstein, Rosalind J Carter, S A S Kargbo, Alison P. Albert, Julianne Gee, Ayesha Idriss, Anne Schuchat, Donald Bash-Taqi, Durodami Radcliffe Lisk
Publikováno v:
MMWR supplements. 65(3)
In October 2014, the College of Medicine and Allied Health Sciences of the University of Sierra Leone, the Sierra Leone Ministry of Health and Sanitation, and CDC joined the global effort to accelerate assessment and availability of candidate Ebola v
Autor:
Maria F. Gallo, Denise J. Jamieson, Athena P. Kourtis, Tina Hylton-Kong, Jennifer Legardy-Williams, Markus J. Steiner, Carole Rattray
Publikováno v:
Obstetrics and gynecology. 127(3)
OBJECTIVE: To evaluate initiation of a two-rod 150-mg levonorgestrel contraceptive implant on womens perceived and observed body weight. METHODS: We conducted a secondary analysis of data from an open randomized controlled trial of adult nonpregnant